Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.12.2018 | editorial

BEST of ASCO 2018

verfasst von: Univ. Prof. Prim. Dr. Josef Thaler

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Excerpt

The library of the 2018 annual meeting of the American Society of Clinical Oncology (ASCO) contains 6251 contributions including a range of practice-changing presentations. A selection of major topics from this meeting were presented and discussed in the officially licensed “Best of ASCO” meeting in Vienna on June 22 and 23, 2018. Austrian experts and speakers of this meeting were invited to summarize and discuss the most important and clinically relevant data from the 2018 ASCO meeting in this special memo edition. …
Nächster Artikel Personalized prostate cancer diagnosis and treatment—are we ready?
Literatur
1.
2.
Conroy T, Hammel P, Hebbar M, et al. Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine in patients with resected pancreatic ductal adenocarcinomas. 2018 ASCO Annual Meeting. J Clin Oncol. 2018;36(suppl):abstr LBA 4001.CrossRef
3.
4.
5.
Metadaten
Titel
BEST of ASCO 2018
verfasst von
Univ. Prof. Prim. Dr. Josef Thaler
Publikationsdatum
01.12.2018
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0453-6

Weitere Artikel der Ausgabe 4/2018

The impact of surgery in oligometastatic prostate cancer

  • short review

ASCO 2018: highlights of urothelial cancer and prostate cancer

  • Open Access
  • short review

ASCO 2018: highlights in HER2-positive metastatic breast cancer

  • Open Access
  • short review

A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment

  • case report

Aggressive variant and treatment-related neuroendocrine prostate cancer: two different terms for the same disease?

  • short review

The ASCO 2018 annual meeting: update on the adjuvant treatment of early breast cancer

  • short review